American Council of Learned Societies Collaborating with The Robert H. N. Ho Family Foundation Global and Yale University Press on Major Book Series
NEW YORK,...
STOCKHOLM, SWEDEN – July 3, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces an update from Organon on the development of the drug candidate OG-6219, acquired by Organon through its acquisition of Forendo Pharma in 2021. Following results from a Phase 2 clinical study with OG-6219, Organon plans to discontinue the clinical development of the drug candidate.
WICHITA, Kan., July 2, 2025 /PRNewswire/ -- Fast-casual restaurant concept, Freddy's Frozen Custard & Steakburgers®, announced today the launch of its new Dr Pepper Frost...
Over $100,000 in financial and technology grants awarded globally to support educators and innovation
NEW YORK, July 1, 2025 /PRNewswire/ -- Echo360, the global leader in transformative...
SHANGHAI, July 1, 2025 /PRNewswire/ -- Club Med, part of Fosun Tourism Group, proudly marks its 75th Anniversary in 2025 with global celebrations honoring its French...
CHAM, Switzerland, July 1, 2025 /PRNewswire/ -- The wait is over: Racing Unleashed is officially opening its new Flagship Racing Lounge at Zurich's Europaallee...